跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 967 条关于
“dedifferentiated liposarcoma”
全部
967
临床试验
913
药物
3
机构
0
资讯
51
去年
Trabectedin and Nivolumab Combination Shows Promise in Long-Term Control of Dedifferentiated Liposarcoma
去年
Brigimadlin Shows Promise in Treating Dedifferentiated Liposarcoma
3个月前
Abemaciclib Demonstrates Significant Efficacy in Phase 3 Trial for Rare Dedifferentiated Liposarcoma
去年
Novel Sarcoma Therapies Show Promise in Early-Phase Studies at ESMO 2024
去年
Pembrolizumab Plus Radiation and Surgery Improves Outcomes in Stage III Soft-Tissue Sarcoma
去年
Pembrolizumab Plus Radiotherapy and Surgery Improves DFS in Stage III Soft Tissue Sarcoma
去年
Siremadlin Plus Ribociclib Shows Promise in MDM2/CDK4-Amplified Liposarcoma
2年前
Boehringer Ingelheim Plans 25 New Treatments by 2030, Bolstered by Oncology and Metabolic Disease Programs
3个月前
Trabectedin Plus Radiotherapy Shows Promise in Retroperitoneal Sarcoma Treatment
去年
Immunotherapy Advances in Sarcoma Treatment: Targeting the Tumor Microenvironment and Cancer Testis Antigens
第 1 页,共 6 页
上一页
下一页